MANCHA
ActiveFrom the official registers: KBO 9 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
MANCHA has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€12,895) and a net result of €39,608. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 12% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Financials · financial year 2025, abbreviated format
Annual accounts 2025
- Financial year ended
- 31-12-2025
- Filed on
- 20-07-2026
- Format
- abbreviated format
- Reference
- 2026-00319693
Amounts without an identifiable currency are taken as euros.
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result for 2025 is 16% higher than in 2024 and the highest since 2021. It is the second rise in a row, after the fall in 2023.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Retail trade (NACE 47). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
- 2021 Net result -84% on 2020. The accounts now follow the abbreviated format, last year the micro format.
Companies with the same profile, two years later
Historical observationIn July 2024, 2,180 companies had the same profile as MANCHA has now. Two years later, 4.8% had gone bankrupt and 88.8% were still going.
- Micro
- 5 to 10 years old
- negative equity
- a profit of 5% of the balance sheet or more
Another 0.6% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of MANCHA itself: 1.0% within 12 months.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,180 companies, not a prediction for MANCHA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €50,922 | €51,208 | €34,284 | €333 | €231 | €36,846 | €19,383 | €19,643 | ▲ 1.3% |
| Other operating charges640/8 | - | - | - | €1,804 | €525 | €1,517 | €2,201 | €2,264 | ▲ 2.8% |
| Non-recurring operating charges66A | - | - | - | €13,089 | - | - | - | - | - |
| Gross operating margin9900 | -€4,272 | €70,451 | €257,057 | €41,256 | €36,843 | €35,840 | €63,347 | €70,203 | ▲ 10.8% |
| Operating profit (loss)9901 | -€123,950 | -€91,598 | €138,679 | €26,029 | €36,087 | -€2,524 | €41,762 | €48,297 | ▲ 15.6% |
| Financial income75/76B | - | - | - | €294 | €89 | €238 | - | - | - |
| Recurring financial income75 | - | - | - | €294 | €89 | €238 | - | - | - |
| Financial charges65/66B | - | - | - | €5,282 | €4,305 | €6,502 | €9,775 | €8,688 | ▼ 11.1% |
| Recurring financial charges65 | €4,470 | €8,437 | €7,542 | €5,282 | €4,305 | €6,502 | €9,775 | €8,688 | ▼ 11.1% |
| Profit (loss) for the period before taxes9903 | -€128,420 | -€100,035 | €131,137 | €21,042 | €31,871 | -€8,788 | €31,987 | €39,608 | ▲ 23.8% |
| Profit (loss) for the period9904 | -€128,420 | -€100,035 | €131,137 | €21,042 | €31,871 | -€8,788 | €31,987 | €39,608 | ▲ 23.8% |
| Profit (loss) for the period to be appropriated9905 | -€128,420 | -€100,035 | €131,137 | €21,042 | €31,871 | -€8,788 | €31,987 | €39,608 | ▲ 23.8% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €619,875 | €548,053 | €601,671 | €155,075 | €142,505 | €294,591 | €279,120 | €264,945 | ▼ 5.1% |
| Fixed assets21/28 | €426,588 | €378,237 | €223,771 | €14,303 | €16,743 | €275,459 | €262,602 | €245,477 | ▼ 6.5% |
| Intangible fixed assets21 | €119,128 | €104,237 | - | - | - | - | - | - | - |
| Tangible fixed assets22/27 | €307,460 | €274,000 | €223,771 | €14,303 | €16,743 | €275,459 | €262,602 | €245,477 | ▼ 6.5% |
| Land and buildings22 | - | - | - | €9,868 | €9,637 | €235,076 | €219,426 | €203,775 | ▼ 7.1% |
| Furniture and vehicles24 | - | - | - | - | - | - | - | €950 | - |
| Other tangible fixed assets26 | - | - | - | €4,435 | €7,106 | €40,382 | €43,176 | €40,752 | ▼ 5.6% |
| Current assets29/58 | €193,287 | €169,817 | €377,900 | €140,772 | €125,762 | €19,132 | €16,517 | €19,468 | ▲ 17.9% |
| Stocks and contracts in progress3 | €85,091 | €81,173 | - | - | - | - | - | - | - |
| Amounts receivable within one year40/41 | €13,553 | €22,082 | €3,500 | €2,202 | - | €2,112 | €4,429 | €2,338 | ▼ 47.2% |
| Trade receivables40 | - | - | - | €2,202 | - | - | €4,429 | €2,336 | ▼ 47.2% |
| Other amounts receivable41 | - | - | - | - | - | €2,112 | - | €2 | - |
| Cash at bank and in hand54/58 | €89,742 | €59,701 | €368,673 | €138,570 | €125,762 | €16,611 | €11,662 | €16,686 | ▲ 43.1% |
| Deferred charges and accrued income490/1 | - | - | - | - | - | €409 | €427 | €444 | ▲ 4.0% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €619,875 | €548,053 | €601,671 | €155,075 | €142,505 | €294,591 | €279,120 | €264,945 | ▼ 5.1% |
| Equity10/15 | -€165,866 | -€265,902 | -€134,765 | -€113,723 | -€81,852 | -€84,491 | -€52,503 | -€12,895 | ▲ 75.4% |
| Contributions10/11 | €12,400 | €12,400 | - | €12,400 | €12,400 | €18,550 | €18,550 | €18,550 | = |
| Profit (loss) carried forward14 | -€178,266 | -€278,302 | -€147,165 | -€126,123 | -€94,252 | -€103,041 | -€71,053 | -€31,445 | ▲ 55.7% |
| Amounts payable17/49 | €785,741 | €813,955 | €736,436 | €268,798 | €224,358 | €379,081 | €331,623 | €277,840 | ▼ 16.2% |
| Amounts payable after more than one year17 | €347,741 | €301,650 | €258,041 | €218,605 | €178,481 | €323,897 | €271,602 | €218,191 | ▼ 19.7% |
| Financial debts170/4 | - | - | - | €218,605 | €178,481 | €323,897 | €271,602 | €218,191 | ▼ 19.7% |
| Amounts payable within one year42/48 | €437,902 | €508,238 | €474,469 | €46,561 | €42,245 | €53,452 | €53,265 | €54,579 | ▲ 2.5% |
| Current portion of amounts payable after more than one year42 | - | - | - | €39,436 | €40,124 | €51,205 | €52,295 | €53,411 | ▲ 2.1% |
| Trade debts44 | €16,807 | €35,955 | €611 | €421 | €30 | €309 | €575 | €192 | ▼ 66.7% |
| Suppliers440/4 | - | - | - | €421 | €30 | €309 | €575 | €192 | ▼ 66.7% |
| Taxes, remuneration and social security45 | - | - | - | €3,542 | €2,091 | €1,938 | €395 | €977 | ▲ 148% |
| Taxes450/3 | - | - | - | €3,542 | €2,091 | €1,938 | €395 | €977 | ▲ 148% |
| Other amounts payable47/48 | - | - | - | €3,162 | - | - | - | - | - |
| Accrued charges and deferred income492/3 | - | - | - | €3,632 | €3,632 | €1,733 | €6,756 | €5,070 | ▼ 25.0% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€128,420 | -€100,035 | €131,137 | €21,042 | €31,871 | -€8,788 | €31,987 | €39,608 | ▲ 23.8% |
| + Depreciation and write-downs630 | €50,922 | €51,208 | €34,284 | €333 | €231 | €36,846 | €19,383 | €19,643 | ▲ 1.3% |
| Operating cash flow (approximation) | -€77,497 | -€48,827 | €165,421 | €21,375 | €32,102 | €28,058 | €51,370 | €59,251 | ▲ 15.3% |
| Investment in fixed assets (approximation) | - | -€2,857 | €120,182 | €209,135 | -€2,672 | -€295,562 | -€6,526 | -€2,518 | ▲ 61.4% |
| Change in cash | - | -€30,041 | €308,972 | -€230,102 | -€12,808 | -€109,151 | -€4,950 | €5,024 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Filings with the National Bank (9)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 20-07-2026 | 2026-00319693 | NBB |
| 31-12-2024 | abbreviated format | 12-08-2025 | 2025-00373283 | |
| 31-12-2023 | abbreviated format | 29-08-2024 | 2024-00393816 | |
| 31-12-2022 | abbreviated format | 30-08-2023 | 2023-00375938 | |
| 31-12-2021 | abbreviated format | 30-08-2022 | 2022-20358592 | |
| 31-12-2020 | micro format | 25-08-2021 | 2021-52500344 | |
| 31-12-2019 | micro format | 24-08-2020 | 2020-44100248 | |
| 31-12-2018 | micro format | 29-08-2019 | 2019-54400291 | |
| 31-12-2017 | micro format | 06-08-2018 | 2018-43400465 |
Comparable companies
These companies have the same main activity as MANCHA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €222,000 and €308,000, founded between 2015 and 2018.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| MANCHA Edegem | 2016 | €264,945 | -€12,895 | €70,203 | €39,608 | - | 2025 |
| PHARMACIE VAN HONG Brussel | 2016 | €251,566 | €71,049 | €75,636 | €8,870 | - | 2025 |
| GEASSOCIEERDE APOTHEEK DE RIDDER Ninove | 2016 | €231,024 | -€28,792 | €66,026 | -€17,757 | 1 | 2025 |
| 3Pharma Sint-Niklaas | 2016 | €307,833 | -€18,557 | €84,337 | -€3 | - | 2025 |
| GILSON MARIE-CLAIRE Vaux-sur-Sûre | 2015 | €221,736 | €192,807 | €68,923 | €42,444 | - | 2025 |
| PHARMACIE DE LA PLACE ALBERT Vorst | 2018 | €266,481 | €100,024 | €59,392 | €13,112 | - | 2025 |
| PHARMACIE WILLEMSEN Anderlecht | 2017 | €307,927 | €230,714 | €86,114 | €35,137 | - | 2025 |
They were chosen from the 3,936 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.